Expert explores fast-acting depression treatments, psilocybin trial pitfalls, and why stigma still limits buprenorphine access for opioid use disorder.
Jason Kellogg, MD
Advertisement
Articles by Jason Kellogg, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Tribalism in Psychiatry: On the Mind of John J. Miller, MD
2
Positive Phase 3 Data for Centanafadine to Treat Comorbid ADHD and Anxiety
3
The Top 10 Misleading Claims About Antidepressants
4
The Psychiatric Pipeline in Review: Quarter 2, 2026
5